» Articles » PMID: 19304907

Lung Environment Determines Unique Phenotype of Alveolar Macrophages

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Alveolar macrophages (AM) are the most abundant antigen-presenting cells in the lungs, and they play a critical role in regulating pulmonary immune responses to inhaled pathogens and to allergens. However, compared with macrophages in other body sites, AM have an unusual phenotype that, in many respects, resembles the phenotype of dendritic cells (DC). Therefore, to more fully define the unique nature of AM, we compared the phenotype and function of AM with the phenotype and function of resident peritoneal lavage-derived macrophages (PLM). We found striking phenotypic differences between AM and PLM, particularly with regard to CD11c expression, and we also observed that AM had a significantly better antigen-presenting capability than PLM. Therefore, we investigated the role of the local airway environment in generation of the unusual phenotype of AM. We carried out cell transfer experiments to compare macrophage differentiation in the airways with that in the peritoneal cavity. We observed significant upregulation of CD11c expression on bone marrow macrophages and peritoneal macrophages when they were adoptively transferred into the airways. In contrast, CD11c expression was not upregulated after cell transfer into the peritoneal cavity, whereas CD11b expression was significantly increased. In vitro, culture of bone marrow-adherent cells with surfactant protein D (SP-D) or granulocyte/macrophage colony-stimulating factor (GM-CSF) induced significant upregulation of CD11c expression, and in vivo GM-CSF concentrations were significantly higher in bronchoalveolar than in peritoneal lavage fluid. Finally, GM-CSF(-/-) mice failed to develop CD11c(+) AM, but CD11c(+) AM were present in SP-D(-/-) mice. However, macrophages from GM-CSF(-/-) bone marrow could upregulate CD11c expression when transferred to the airways of wild-type mice. These results suggest that the airway environment promotes development of macrophages with unique DC-like characteristics and that this unusual phenotype is determined, to a large degree, by locally high concentrations of GM-CSF and, possibly, SP-D.

Citing Articles

Antibiotic use during influenza infection augments lung eosinophils that impair immunity against secondary bacterial pneumonia.

Sanches Santos Rizzo Zuttion M, Parimon T, Bora S, Yao C, Lagree K, Gao C J Clin Invest. 2024; 134(21).

PMID: 39255040 PMC: 11527449. DOI: 10.1172/JCI180986.


Flagellin-modulated inflammasome pathways characterize the human alveolar macrophage response to , a lung-tropic pathogen.

Lovelace-Macon L, Baker S, Ducken D, Seal S, Rerolle G, Tomita D Infect Immun. 2024; 92(5):e0006024.

PMID: 38619302 PMC: 11075458. DOI: 10.1128/iai.00060-24.


The scene of lung pathology during PRRSV-1 infection.

Ruedas-Torres I, Sanchez-Carvajal J, Salguero F, Pallares F, Carrasco L, Mateu E Front Vet Sci. 2024; 11:1330990.

PMID: 38566751 PMC: 10985324. DOI: 10.3389/fvets.2024.1330990.


Interstitial Macrophages Mediate Efferocytosis of Alveolar Epithelium during Influenza Infection.

Zuttion M, Parimon T, Yao C, Stripp B, Wang Y, Soto C Am J Respir Cell Mol Biol. 2024; 70(3):159-164.

PMID: 38207122 PMC: 10914771. DOI: 10.1165/rcmb.2023-0217MA.


Integrated multi-omics analyses reveal the altered transcriptomic characteristics of pulmonary macrophages in immunocompromised hosts with .

Wang Y, Li K, Zhao W, Liu Y, Li T, Yang H Front Immunol. 2023; 14:1179094.

PMID: 37359523 PMC: 10289015. DOI: 10.3389/fimmu.2023.1179094.


References
1.
Sallusto F, Cella M, Danieli C, Lanzavecchia A . Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med. 1995; 182(2):389-400. PMC: 2192110. DOI: 10.1084/jem.182.2.389. View

2.
Bosio C, Goodyear A, Dow S . Early interaction of Yersinia pestis with APCs in the lung. J Immunol. 2005; 175(10):6750-6. DOI: 10.4049/jimmunol.175.10.6750. View

3.
Thomassen M, Barna B, Malur A, Bonfield T, Farver C, Malur A . ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis. J Lipid Res. 2007; 48(12):2762-8. DOI: 10.1194/jlr.P700022-JLR200. View

4.
Chitu V, Stanley E . Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol. 2005; 18(1):39-48. DOI: 10.1016/j.coi.2005.11.006. View

5.
Janssen W, McPhillips K, Dickinson M, Linderman D, Morimoto K, Xiao Y . Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP alpha. Am J Respir Crit Care Med. 2008; 178(2):158-67. PMC: 2453510. DOI: 10.1164/rccm.200711-1661OC. View